Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Neurocognitive measures of self-blame and risk prediction models of recurrence in major depressive disorder

View ORCID ProfileAndrew J. Lawrence, Daniel Stahl, Suqian Duan, Diede Fennema, Tanja Jaeckle, Allan H. Young, Paola Dazzan, Jorge Moll, Roland Zahn
doi: https://doi.org/10.1101/2021.01.13.21249739
Andrew J. Lawrence
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychological Medicine, Centre for Affective Disorders, King’s College London, London, SE5 8AZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Lawrence
Daniel Stahl
2Department of Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suqian Duan
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychological Medicine, Centre for Affective Disorders, King’s College London, London, SE5 8AZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diede Fennema
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychological Medicine, Centre for Affective Disorders, King’s College London, London, SE5 8AZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanja Jaeckle
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychological Medicine, Centre for Affective Disorders, King’s College London, London, SE5 8AZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan H. Young
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychological Medicine, Centre for Affective Disorders, King’s College London, London, SE5 8AZ, UK
4National Service for Affective Disorders, South London and Maudsley NHS Foundation Trust, London SE5 8AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Dazzan
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychological Medicine, Centre for Affective Disorders, King’s College London, London, SE5 8AZ, UK
4National Service for Affective Disorders, South London and Maudsley NHS Foundation Trust, London SE5 8AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Moll
3Cognitive and Behavioral Neuroscience Unit, D’Or Institute for Research and Education (IDOR), 22280-080 -Rio de Janeiro, RJ, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Zahn
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychological Medicine, Centre for Affective Disorders, King’s College London, London, SE5 8AZ, UK
3Cognitive and Behavioral Neuroscience Unit, D’Or Institute for Research and Education (IDOR), 22280-080 -Rio de Janeiro, RJ, Brazil
4National Service for Affective Disorders, South London and Maudsley NHS Foundation Trust, London SE5 8AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: roland.zahn@kcl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Overgeneralised self-blaming emotions, such as self-disgust, are core symptoms of major depressive disorder (MDD) and prompt specific actions (i.e. “action tendencies”), which are more functionally relevant than the emotions themselves. We have recently shown, using a novel cognitive task, that when feeling self-blaming emotions, maladaptive action tendencies (feeling like “hiding” and like “creating a distance from oneself”) and an overgeneralised perception of control are characteristic of MDD, even after remission of symptoms. Here, we probed the potential of this cognitive signature, and its combination with previously employed fMRI measures, to predict individual recurrence risk. For this purpose, we developed a user-friendly hybrid machine-/statistical-learning tool which we make freely available.

Methods 52 medication-free remitted MDD patients, who had completed the Action Tendencies Task and our self-blame fMRI task at baseline, were followed up clinically over 14-months to determine recurrence. Prospective prediction models included baseline maladaptive self-blame-related action tendencies and anterior temporal fMRI connectivity patterns across a set of fronto-limbic a priori regions of interest, as well as established clinical and standard psychological predictors. Prediction models used elastic-net regularised logistic regression with nested 10-fold cross-validation.

Results Cross-validated discrimination was highly promising (AuC≥0.86), and positive predictive values over 80% were achieved when including fMRI in multi-modal models, but only up to 71% (AuC≤.74) when solely relying on cognitive and clinical measures.

Conclusions This shows the high potential of multi-modal signatures of self-blaming biases to predict recurrence risk at an individual level, and calls for external validation in an independent sample.

Competing Interest Statement

RZ is a private psychiatrist service provider at The London Depression Institute, has collaborated with e-health companies Depsee Ltd, EMIS PLC and Alloc Modulo Ltd. He has received honoraria from pharmaceutical companies (Lundbeck, Janssen) for scientific presentations and is a co-investigator for a Livanova-funded study on Vagus Nerve Stimulation. None of the other authors report biomedical financial interests or potential conflicts of interest related to the subject of this paper.

Funding Statement

This study was funded by an MRC Clinician Scientist Fellowship to RZ (G0902304). RZ and DS were partly and AJL fully funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and by a NARSAD Independent Investigator Grant (24715) from the Brain & Behavior Research Foundation. J.M. was supported by the LABS-D'Or Hospital Network, Rio de Janeiro, Brazil. J.A.G. This study was funded by the UK Medical Research Council (G0902304). D.F. was funded by the Medical Research Council Doctoral Training Partnership (Ref: 2064430).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This research was approved by the South Manchester National Health Service Research Ethics Committee. All participants have given written informed consent after the procedures of the study have been fully explained.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The dataset used in this publication is available upon request, subject to a Data Access Agreement.

http://doi.org/doi:10.18742/RDM01-482

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Neurocognitive measures of self-blame and risk prediction models of recurrence in major depressive disorder
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Neurocognitive measures of self-blame and risk prediction models of recurrence in major depressive disorder
Andrew J. Lawrence, Daniel Stahl, Suqian Duan, Diede Fennema, Tanja Jaeckle, Allan H. Young, Paola Dazzan, Jorge Moll, Roland Zahn
medRxiv 2021.01.13.21249739; doi: https://doi.org/10.1101/2021.01.13.21249739
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Neurocognitive measures of self-blame and risk prediction models of recurrence in major depressive disorder
Andrew J. Lawrence, Daniel Stahl, Suqian Duan, Diede Fennema, Tanja Jaeckle, Allan H. Young, Paola Dazzan, Jorge Moll, Roland Zahn
medRxiv 2021.01.13.21249739; doi: https://doi.org/10.1101/2021.01.13.21249739

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1435)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10335)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2656)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (682)
  • Hematology (269)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2484)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1335)
  • Ophthalmology (403)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2422)
  • Public and Global Health (5032)
  • Radiology and Imaging (902)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)